Nalpac recalls DTF Sexual Chocolate over undeclared sildenafil and tadalafil

FERNDALE, MI (April 7, 2026) — The U.S. Food and Drug Administration (FDA) has announced a voluntary nationwide recall issued by Nalpac of Ferndale, Michigan, covering DTF Sexual Chocolate due to the presence of undeclared sildenafil and tadalafil. According to the FDA, the product contains the active pharmaceutical ingredients found in the prescription drugs Viagra and Cialis, neither of which appears on the product label. The agency confirmed that these undeclared compounds can interact with nitrate-based prescription medications and may cause a dangerous drop in blood pressure that puts consumers at serious risk.

Nalpac recall: Quick summary

Nalpac, a Michigan-based adult products distributor, announced a voluntary recall on April 6, 2026, for DTF Sexual Chocolate after the product was found to contain undeclared sildenafil and tadalafil. Nalpac clarifies it is not the manufacturer of this product but purchased and resold it. The recalled product was available through adult retail stores as well as the websites shopsexology.com and royalsins.com. No adverse events have been reported to date. Consumers and retailers in possession of the product should stop using or selling it immediately and return it or discard it.

What happened?

The FDA said Nalpac initiated the voluntary recall on April 6, 2026, after the product was found to contain sildenafil and tadalafil, the active pharmaceutical ingredients in the prescription drugs Viagra and Cialis, respectively. The FDA published the recall alert on April 7, 2026.

Nalpac stated clearly in its recall notice that it is not the manufacturer of DTF Sexual Chocolate. The company purchased and resold the product. The FDA had already flagged DTF Sexual Chocolate in a public health advisory issued on February 13, 2026, warning consumers not to purchase or use the product after laboratory analysis confirmed the presence of sildenafil and tadalafil. The April recall formalizes that alert at the distributor level.

In its recall notice, Nalpac warned that the undeclared ingredients “could interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels for those individuals who use prescription drugs which contain nitrates.”

The company confirmed it has not received any reports of adverse events related to this recall.

Affected products

Brand	Product	Packaging	UPC	Lot number	Issue	Affected states
DTF Sexual Chocolate	DTF Sexual Chocolate	Cases of 20 retail units	757817783069	Not specified	Undeclared sildenafil and tadalafil	Nationwide

What caused the issue?

The recall stems from the presence of undeclared active pharmaceutical ingredients in a product sold as a sexual enhancement food item. DTF Sexual Chocolate contains sildenafil and tadalafil, PDE-5 inhibitors approved by the FDA as prescription drugs for the treatment of erectile dysfunction, but the product label does not disclose their presence.

Why this is a serious health risk

Sildenafil and tadalafil are legal and effective when prescribed by a licensed healthcare professional. The danger arises when they appear in a product without disclosure. Consumers taking nitrate-based prescription medications, including nitroglycerin for cardiac conditions, face the risk of a sudden and dangerous drop in blood pressure if they unknowingly consume these compounds. According to the FDA, people managing diabetes, high blood pressure, high cholesterol, or heart disease are the most at risk, because they are more likely to use nitrate medications alongside other treatments.

The FDA first identified the issue with DTF Sexual Chocolate in February 2026 through its own laboratory analysis. At that time, the agency issued a public health advisory urging consumers not to buy or use the product. The April 6, 2026 recall by Nalpac represents a formal action at the distributor level to remove the product from commerce.

The broader pattern

This recall is the latest in a series of similar incidents involving hidden prescription drug compounds in sexual enhancement products marketed as chocolates or supplements. The problem is persistent and concentrated in the adult novelty product sector. Regulators have tracked multiple recalls involving these same two compounds in recent weeks alone.

Questions you might have

1. What product is being recalled? The recall covers DTF Sexual Chocolate, sold in cases of 20 retail units with UPC 757817783069. The product was available at adult retail stores and through the websites shopsexology.com and royalsins.com. All units are included in the recall.
2. Who issued this recall, and why isn’t it from the manufacturer? Nalpac, a Michigan-based adult products distributor, issued the recall as the company that purchased and resold the product. Nalpac states it is not the manufacturer of DTF Sexual Chocolate. The FDA encourages distributors to issue recalls when manufacturers do not or cannot, and Nalpac acted voluntarily once the product was identified as containing undeclared pharmaceutical ingredients.
3. What are sildenafil and tadalafil, and why are they dangerous in an unlabeled product? Sildenafil is the active ingredient in Viagra, and tadalafil is the active ingredient in Cialis. Both are prescription drugs approved by the FDA for the treatment of erectile dysfunction. Their danger in an unlabeled product comes from the risk of drug interactions. When combined with nitrate medications, such as nitroglycerin, both compounds can cause a severe and potentially fatal drop in blood pressure. Consumers who take these medications have no way of knowing the risk if the label does not disclose the ingredients.
4. Who is most at risk from this product? Adult men who use nitrate medications for cardiac conditions face the greatest risk. This includes people managing angina, coronary artery disease, or other heart conditions. People with diabetes, high blood pressure, high cholesterol, or heart disease are also more likely to use nitrates. Even men without these conditions should stop using the product and consult a physician if they have consumed it.
5. Were any adverse events or illnesses reported? No. As of the recall announcement on April 6, 2026, Nalpac confirmed it had not received any reports of adverse events related to this product. Consumers who experience health problems they believe may be connected to this product should contact a physician and can report issues to the FDA’s MedWatch program at fda.gov/medwatch or by calling 1-800-332-1088.
6. Can I get a refund or return? Yes. Consumers and retailers should stop using or selling the product and return it to the place of purchase. Contact Nalpac directly at 248-541-1140 or [email protected], Monday through Friday, 8 a.m. to 4:30 p.m. EST.
7. Why can’t sildenafil and tadalafil appear in a food or supplement product? The FDA prohibits the inclusion of active pharmaceutical ingredients in products marketed as food or dietary supplements. Sildenafil and tadalafil require a prescription precisely because of their known interaction risks and potential side effects. Selling them in a chocolate product without disclosure bypasses the medical oversight that protects consumers from harm.
8. Is this a voluntary recall or was it ordered by the FDA? This is a voluntary recall initiated by Nalpac. It follows a February 2026 FDA public health advisory that flagged DTF Sexual Chocolate as unsafe. The recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
9. Where was this product sold? DTF Sexual Chocolate was distributed nationwide through adult retail stores and through the websites shopsexology.com and royalsins.com. The product was sold in cases of 20 retail units.
10. Should I report my experience to the FDA? Yes, if you experienced any adverse effects after consuming this product. Reports can be submitted online through the FDA’s MedWatch Adverse Event Reporting Program at www.fda.gov/medwatch/report.htm, by mail, or by fax to 1-800-FDA-0178.

Here’s what you should do

• What to do with the product: Stop using it immediately. Return it to the place of purchase or discard it safely.
• Where to look on the label: Check the UPC code on the product. The recalled DTF Sexual Chocolate carries UPC 757817783069.
• How to identify the affected product: All units of DTF Sexual Chocolate carrying UPC 757817783069, sold in cases of 20 retail units through adult stores or via shopsexology.com and royalsins.com, are included in this recall.
• Brand contact details: Nalpac: 248-541-1140 or [email protected], Monday through Friday, 8 a.m. to 4:30 p.m. EST.

Behind the brand

Nalpac is a Ferndale, Michigan-based wholesale distributor specializing in adult novelty products, health and wellness items, and lifestyle accessories. The company supplies adult retail stores across the United States and operates as a distributor rather than a manufacturer. In this recall, Nalpac acted as the responsible party for removing the product from the market after purchasing and reselling DTF Sexual Chocolate from a third party manufacturer whose identity has not been publicly disclosed.

Source86 reached out to Nalpac for additional comment on how the product came to be stocked and resold without knowledge of its pharmaceutical content, but has not yet received a response beyond the company’s published recall notice.

Other relevant recalls

The Nalpac recall is the latest in a rapidly growing series of sexual enhancement chocolate and supplement recalls driven by the same two undisclosed pharmaceutical compounds. In March 2026, Gear Isle recalled its Gold Lion Aphrodisiac Chocolate Sachet and ilum Sex Chocolate after both were found to contain undeclared sildenafil and tadalafil, distributed nationwide through internet sales. In February 2026, Lockout Supplements recalled all lots of its Boner Bears chocolate syrup after the product was found to contain undisclosed sildenafil. That same month, Pure Vitamins and Natural Supplements recalled its Boner Bears Honey and two erotic honey products after FDA lab analysis confirmed the presence of sildenafil and tadalafil. The FDA had also already flagged DTF Sexual Chocolate specifically in a public health advisory in February 2026, making this recall the formal follow-up to a known product risk. Beyond the chocolate and supplement category, USALESS.COM recalled its Rhino Choco VIP 10X chocolate supplement in March 2026 over undeclared tadalafil, underscoring how deeply embedded this compliance problem is in the sexual enhancement product market.

A pharmacologist familiar with PDE-5 inhibitor interactions noted the particular concern these recalls raise for unsuspecting consumers:

“Someone picking up a novelty chocolate in a gift shop or ordering it online has no reason to expect it contains a prescription cardiac medication. For a man on nitroglycerin, consuming even a small amount of undisclosed sildenafil could be a medical emergency.”

A food safety attorney added:

“The fact that the manufacturer is unnamed in this recall is itself a red flag. Distributors have an obligation to vet the products they sell, and when pharmaceutical adulterants show up in food items, the supply chain failure is comprehensive.”

Eran Mizrahi, CEO of Source86, said the Nalpac recall reflects a systemic problem that extends well beyond any single product:

“Food safety isn’t just about compliance; it’s about trust. Every recall reminds us how vital it is to maintain transparency, rigorous checks, and supplier accountability. That includes distributors who must verify the safety of every product they put their name behind.”

Ensuring safe eats

The DTF Sexual Chocolate recall is a serious reminder that products sold as food or supplements can contain undisclosed pharmaceutical compounds that carry real health risks. For consumers who take prescription medications for heart conditions, encountering an unlabeled PDE-5 inhibitor in a chocolate product is not a minor inconvenience. It is a potential medical emergency.

If you purchased DTF Sexual Chocolate through any adult retailer or via shopsexology.com or royalsins.com, stop using the product immediately and dispose of it or return it. Contact a physician if you have consumed it and take any prescription medications.

At Source86, we help food brands manage ingredient sourcing, FSQA oversight, and private label production with transparency and precision, ensuring that when recalls happen, supply chains are prepared to respond quickly. Our team works directly with manufacturers and distributors to implement the ingredient verification and supplier audit protocols that prevent issues like this from reaching consumers in the first place. Reach out to learn how Source86 can support your brand’s food safety program.